| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,945 |
10,815 |
$829K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,675 |
6,990 |
$776K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,010 |
2,800 |
$257K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,270 |
2,239 |
$208K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,339 |
1,321 |
$125K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
575 |
564 |
$58K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,658 |
1,552 |
$51K |
| 99381 |
|
269 |
262 |
$24K |
| 99174 |
|
5,416 |
5,328 |
$20K |
| 36416 |
|
6,563 |
6,444 |
$19K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,936 |
1,868 |
$17K |
| 90670 |
|
1,069 |
1,045 |
$16K |
| 85018 |
|
6,658 |
6,539 |
$14K |
| 90686 |
|
959 |
948 |
$12K |
| 90680 |
|
804 |
787 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
850 |
821 |
$7K |
| 90671 |
|
441 |
433 |
$7K |
| 96127 |
|
1,846 |
1,794 |
$6K |
| 90698 |
|
363 |
356 |
$5K |
| 90633 |
|
331 |
320 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
254 |
243 |
$5K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
393 |
388 |
$4K |
| 88738 |
|
975 |
961 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
213 |
198 |
$4K |
| 90688 |
|
238 |
236 |
$4K |
| 90648 |
|
230 |
227 |
$4K |
| 90697 |
|
161 |
159 |
$3K |
| 90672 |
|
190 |
186 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
170 |
166 |
$2K |
| 90723 |
|
142 |
140 |
$2K |
| 90651 |
|
157 |
153 |
$2K |
| 99215 |
Prolong outpt/office vis |
16 |
15 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,977 |
4,817 |
$2K |
| 99382 |
|
12 |
12 |
$1K |
| 99383 |
|
12 |
12 |
$1K |
| 90716 |
|
66 |
66 |
$1K |
| 96161 |
|
738 |
719 |
$973.32 |
| 90685 |
|
56 |
54 |
$890.50 |
| 90707 |
|
41 |
41 |
$670.34 |
| 95012 |
|
48 |
44 |
$547.35 |
| 90744 |
|
26 |
26 |
$470.75 |
| 90734 |
|
27 |
27 |
$439.29 |
| 90461 |
|
2,512 |
2,458 |
$350.70 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
29 |
29 |
$309.50 |
| 90696 |
|
14 |
12 |
$184.93 |
| 81002 |
|
53 |
49 |
$147.50 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
15 |
13 |
$97.56 |
| 90619 |
|
12 |
12 |
$26.20 |
| 2001F |
|
45 |
45 |
$0.00 |
| 2010F |
|
40 |
40 |
$0.00 |
| 90473 |
|
41 |
41 |
$0.00 |